CircuLite Inc. landed $30 million in an oversubscribed Series D financing round led by McAndrews & Forbes Holdings Inc. and Forbion Capital Partners.
The Saddle Brook, N.J.-based company will use the funds to support the European commercial launch of its Synergy circulatory support system and to fund an investigational device exemption pilot study in the U.S.
CircuLite touts Synergy as the world’s smallest implantable heart pump, saying it’s roughly the size of a AA battery. The company expects to receive European Union CE Mark approval for the system during the first half of 2012.